Trump's drug price order hits PBMs hardest: CVS, Cigna, UNH in focus as experts highlight 'racket,' pricing distortion

By Benzinga
| May 19, 2025

After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how PBMs could be hit the hardest despite pharmaceutical companies facing the potential of compressed margins amid poor pricing power.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...